The excitation power was set to 80%, and the temperature was set to increase from 20 C to 95 C with a temperature ramp rate of 1 C per min
Access and coverage are key hurdles
Pancreatitis, though uncommon with an incidence of less than one percent, represents a potentially serious complication that requires immediate medical attention
Insurance and coverage notes Insurance coverage for retatrutide is not currently available through normal prescription-benefit channels because retatrutide is not FDA-approved for any indication
Treatment with 3 mg liraglutide for 20 weeks reduced appetite and energy intake, resulting in a significant weight loss (7.2 kg) in a large, RCT in people with obesity [15]
While there may be some cases where patients safely used the drug under medical supervision, this information is limited and not enough to draw a firm conclusion